Literature DB >> 16006781

Dominant optic atrophy caused by a novel OPA1 splice site mutation (IVS20+1G-->A) associated with intron retention.

Takaaki Hayashi1, Tamaki Gekka, Satoshi Omoto, Tomokazu Takeuchi, Kenji Kitahara.   

Abstract

Dominant optic atrophy (DOA) is the most common form of inherited primary optic neuropathy. The purpose of the current study was to report a novel OPA1 splice site mutation and investigate the impact of the mutation on pre-mRNA splicing in a female proband and her father diagnosed with DOA. We evaluated visual acuity, retinal fundi and kinetic visual fields. Color vision phenotypes were determined using the Farnsworth Panel D-15 and the Farnsworth-Munsell 100-hue tests. All 28 coding exons of the OPA1 gene were analyzed with polymerase chain reaction (PCR) amplification and direct sequencing. Total RNA extraction from white blood cells followed by reverse transcription-PCR (RT-PCR) was performed. We identified a novel heterozygous G to A mutation at position +1 of intron 20 (g.IVS20+1G-->A) in both patients. RT-PCR analysis revealed that the first 25 bp from intron 20 plus exon 20 were spliced onto exon 21. No difference in expression of mutant and wild-type transcripts was found within the linear range of amplification. Clinically, both patients exhibited reduced visual acuities, pallor of optic discs, decreased sensitivities of central visual fields and blue-yellow color vision defects. Previously, only one mechanism (skipping of exon) of pre-mRNA splicing defects has been reported among OPA1 splice site mutations. Our study demonstrates that the mechanism of intron retention is a novel type of pre-mRNA splicing defects. The mutant transcript with a premature termination codon is likely to encode a truncated protein, due to a translational frameshift (V672fsX675), that lacks 289 amino acids of the C-terminal end. Therefore, it is suggested that haploinsufficiency underlies DOA in the patients. However, we could not exclude the possibility that the truncated protein has a dominant negative activity because the mutant transcript is insusceptible to nonsense-mediated mRNA decay. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16006781     DOI: 10.1159/000086862

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  2 in total

1.  Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy.

Authors:  Takaaki Hayashi; Hiroyuki Sasano; Satoshi Katagiri; Kazushige Tsunoda; Shuhei Kameya; Mitsuru Nakazawa; Takeshi Iwata; Hiroshi Tsuneoka
Journal:  Jpn J Ophthalmol       Date:  2017-07-01       Impact factor: 2.447

2.  Autosomal dominant optic atrophy with OPA1 gene mutations accompanied by auditory neuropathy and other systemic complications in a Japanese cohort.

Authors:  Akiko Maeda-Katahira; Natsuko Nakamura; Takaaki Hayashi; Satoshi Katagiri; Satoko Shimizu; Hisao Ohde; Tatsuo Matsunaga; Kimitaka Kaga; Tadashi Nakano; Shuhei Kameya; Tomokazu Matsuura; Kaoru Fujinami; Takeshi Iwata; Kazushige Tsunoda
Journal:  Mol Vis       Date:  2019-10-05       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.